bpc-157 human clinical trial tendon injury randomized Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats Multifunctionality and Possible Medical Application
Description
Peptide with 99% purity (assassed by high pressure liquid chromatography, HPLC, with the biologically inactive 1-des-Gly peptide as the impurity) was used
Serious side effects may involve: Severe bone marrow suppression (anemia, bleeding, infections)
So, notwithstanding potential differences, heres what you might expect with your CJC-1295 and ipamorelin therapy: Preliminary and ongoing lab tests Your physician may order lab tests to assess your candidacy for CJC-1295 and ipamorelin
Different areas have different tissue depths, nerve densities, and proximity to blood vessels
